The FTC and New York state ac­cuse Mar­tin Shkre­li of run­ning a drug mo­nop­oly. They plan to squash it — and per­ma­nent­ly ex­ile him

Phar­ma bro Mar­tin Shkre­li was jailed, pub­licly pil­lo­ried and forced to con­front some law­mak­ers in Wash­ing­ton riled by his move to take an old gener­ic and move the price from $17.50 per pill to $750. But through 4 years of con­tro­ver­sy and pub­lic re­vul­sion, his com­pa­ny nev­er backed away from the price — left un­con­trolled by a lais­sez faire fed­er­al pol­i­cy on a drug’s cost.

Now the FTC and the state of New York plan to pry his fin­gers off the drug once and for all and open it up to some cheap com­pe­ti­tion. And their law­suit is ask­ing that Shkre­li — with sev­er­al years left on his prison sen­tence — be banned per­ma­nent­ly from the phar­ma in­dus­try.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.